Welcome to our dedicated page for IVC news (Ticker: IVC), a resource for investors and traders seeking the latest updates and insights on IVC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IVC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IVC's position in the market.
Invacare Corporation (NYSE: IVC) announced its participation in two important healthcare conferences in September 2021. The company will take part in the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, and the Baird 2021 Virtual Global Healthcare Conference on September 14. Management, including CEO Matt Monaghan and CFO Kathy Leneghan, will be available for individual meetings with investors during these events. Invacare is a leader in medical equipment for non-acute care, specializing in solutions for various health challenges.
Invacare reported a 15.1% increase in net sales for 2Q21, reaching $225.9 million, aided by 14.9% growth in mobility & seating products and 10.4% in respiratory products. However, gross profit margins decreased by 200 basis points to 26.9%, primarily due to supply chain disruptions. Operating loss widened to $3.5 million, affected by an 11.1% rise in SG&A expenses. Free cash flow usage surged to $27.2 million. Despite challenges, Invacare reaffirms its 2021 guidance, projecting constant currency net sales growth of 4-7% and a $5 million free cash flow for the year.
Invacare Corporation (NYSE: IVC) executives, including Matt Monaghan, Kathy Leneghan, and Lois Lee, will engage in the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 17, 2021. This opportunity allows investors to participate in one-on-one meetings with the management team.
Invacare is a leading manufacturer of medical equipment for non-acute care. It offers solutions for various medical challenges, catering to both active individuals and those in care settings. The company sells its products primarily through home medical equipment providers and distributors across North America, Europe, and Asia/Pacific.
Invacare Corporation (NYSE: IVC) has launched the AVIVA STORM RX power wheelchair, enhancing rear-wheel drive power mobility. This innovative model features a compact design for better maneuverability, with options for high-performance motors (5.8 mph and 7.5 mph). Key highlights include the patent-pending SureGrip™ suspension for a smooth ride, LED lighting for visibility, and customizable aesthetics with eight new color options. The LiNX® technology simplifies setup and programming, offering advanced adaptive load compensation to optimize performance over time.
Invacare Corporation (NYSE: IVC) will release its financial results for Q2 2021 on August 4, 2021, after market close. A conference call to discuss the results is scheduled for August 5, 2021, at 8:30 AM ET. Participants can join via phone or webcast, with access details provided in the press release. The company's products support individuals facing various health challenges, and it serves markets in North America, Europe, and Asia/Pacific. For more information, visit Invacare's investor relations page.
Invacare Corporation (NYSE: IVC) will participate in the 21st Annual New Ideas Summer Conference on July 13, 2021. Key executives, including Matt Monaghan, Kathy Leneghan, and Lois Lee, will be present for one-on-one meetings with investors. Invacare is known for manufacturing medical equipment tailored for non-acute care settings, offering solutions for various health challenges, including congenital and degenerative conditions. Its products cater to home medical equipment providers, residential care operators, and distributors across North America, Europe, and Asia/Pacific.
Invacare Corporation (NYSE:IVC) announced that CEO Matt Monaghan will present at the UBS Global Healthcare Virtual Conference on May 25, 2021, at 4:00 p.m. ET. A live webcast will be available for 30 days post-conference. The management team will also host one-on-one meetings with investors. Invacare is a leading manufacturer of medical equipment for non-acute care settings, producing devices that assist individuals with various health challenges. For more details, visit their investor relations page.
Invacare Corporation (NYSE: IVC) reported a 10.2% decline in net sales for Q1 2021, totaling $196.2 million, primarily due to supply chain disruptions and pandemic-related challenges. Gross profit decreased to 27.8% of net sales, reflecting a 100 basis point drop. The operating loss was $5.7 million, a decline of $15.2 million year-over-year. Despite these challenges, the company anticipates mid-single digit net sales growth for Q2 2021 and reaffirms its full-year guidance for constant currency net sales growth, driven by strong demand and improved supply chain conditions.
Invacare Corporation (NYSE: IVC) will announce its financial results for Q1 2021 after market close on May 5, 2021. A conference call and webcast to discuss these results are scheduled for May 6, 2021, at 8:30 AM ET. Interested parties can participate by calling 888-394-8218 or via webcast on the Invacare investor relations website. A recording will be available through May 13, 2021. Invacare is known for manufacturing medical equipment for non-acute care settings, supporting patients with a range of medical conditions.
Invacare Corporation (NYSE:IVC) announced participation in the 20th Annual Needham Virtual Healthcare Conference on April 12, 2021, at 2:15 p.m. ET. Chairman and CEO Matt Monaghan will host a fireside chat, with a live webcast available at this link. The session will be replayable for 90 days. Additionally, the management team, including CFO Kathy Leneghan and Lois Lee, will be available for one-on-one meetings with investors. An updated investor relations presentation will be accessible on the company's website.
